Ironwood Pharma (IRWD) Misses Q2 EPS by 6c

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $14.6 million versus the consensus estimate of $14.6 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• OfferUp Honors Small Businesses by Spotlighting Entrepreneurs Who Built Their Companies Using the Platform